287 related articles for article (PubMed ID: 20399790)
21. Current knowledge on lower virulence of Reston Ebola virus (in French: Connaissances actuelles sur la moindre virulence du virus Ebola Reston).
Morikawa S; Saijo M; Kurane I
Comp Immunol Microbiol Infect Dis; 2007 Sep; 30(5-6):391-8. PubMed ID: 17610952
[TBL] [Abstract][Full Text] [Related]
22. Cynarin blocks Ebola virus replication by counteracting VP35 inhibition of interferon-beta production.
Corona A; Fanunza E; Salata C; Morwitzer MJ; Distinto S; Zinzula L; Sanna C; Frau A; Daino GL; Quartu M; Taglialatela-Scafati O; Rigano D; Reid S; Mirazimi A; Tramontano E
Antiviral Res; 2022 Feb; 198():105251. PubMed ID: 35066016
[TBL] [Abstract][Full Text] [Related]
23. Expression, purification, crystallization and preliminary X-ray studies of the Ebola VP35 interferon inhibitory domain.
Leung DW; Ginder ND; Nix JC; Basler CF; Honzatko RB; Amarasinghe GK
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 Feb; 65(Pt 2):163-5. PubMed ID: 19194011
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional Analysis of Lymphoid Tissues from Infected Nonhuman Primates Reveals the Basis for Attenuation and Immunogenicity of an Ebola Virus Encoding a Mutant VP35 Protein.
Pinski A; Woolsey C; Jankeel A; Cross R; Basler CF; Geisbert T; Messaoudi I
J Virol; 2021 Feb; 95(6):. PubMed ID: 33408171
[TBL] [Abstract][Full Text] [Related]
25. Human transbodies that interfere with the functions of Ebola virus VP35 protein in genome replication and transcription and innate immune antagonism.
Seesuay W; Jittavisutthikul S; Sae-Lim N; Sookrung N; Sakolvaree Y; Chaicumpa W
Emerg Microbes Infect; 2018 Mar; 7(1):41. PubMed ID: 29568066
[TBL] [Abstract][Full Text] [Related]
26. In silico derived small molecules bind the filovirus VP35 protein and inhibit its polymerase cofactor activity.
Brown CS; Lee MS; Leung DW; Wang T; Xu W; Luthra P; Anantpadma M; Shabman RS; Melito LM; MacMillan KS; Borek DM; Otwinowski Z; Ramanan P; Stubbs AJ; Peterson DS; Binning JM; Tonelli M; Olson MA; Davey RA; Ready JM; Basler CF; Amarasinghe GK
J Mol Biol; 2014 May; 426(10):2045-58. PubMed ID: 24495995
[TBL] [Abstract][Full Text] [Related]
27. Whole-genome expression profiling reveals that inhibition of host innate immune response pathways by Ebola virus can be reversed by a single amino acid change in the VP35 protein.
Hartman AL; Ling L; Nichol ST; Hibberd ML
J Virol; 2008 Jun; 82(11):5348-58. PubMed ID: 18353943
[TBL] [Abstract][Full Text] [Related]
28. Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling.
Cárdenas WB; Loo YM; Gale M; Hartman AL; Kimberlin CR; Martínez-Sobrido L; Saphire EO; Basler CF
J Virol; 2006 Jun; 80(11):5168-78. PubMed ID: 16698997
[TBL] [Abstract][Full Text] [Related]
29. Conservation of Structure and Immune Antagonist Functions of Filoviral VP35 Homologs Present in Microbat Genomes.
Edwards MR; Liu H; Shabman RS; Ginell GM; Luthra P; Ramanan P; Keefe LJ; Köllner B; Amarasinghe GK; Taylor DJ; Leung DW; Basler CF
Cell Rep; 2018 Jul; 24(4):861-872.e6. PubMed ID: 30044983
[TBL] [Abstract][Full Text] [Related]
30. Effects of Filovirus Interferon Antagonists on Responses of Human Monocyte-Derived Dendritic Cells to RNA Virus Infection.
Yen BC; Basler CF
J Virol; 2016 May; 90(10):5108-5118. PubMed ID: 26962215
[TBL] [Abstract][Full Text] [Related]
31. Evasion of interferon responses by Ebola and Marburg viruses.
Basler CF; Amarasinghe GK
J Interferon Cytokine Res; 2009 Sep; 29(9):511-20. PubMed ID: 19694547
[TBL] [Abstract][Full Text] [Related]
32. Recombinant Marburg viruses containing mutations in the IID region of VP35 prevent inhibition of Host immune responses.
Albariño CG; Wiggleton Guerrero L; Spengler JR; Uebelhoer LS; Chakrabarti AK; Nichol ST; Towner JS
Virology; 2015 Feb; 476():85-91. PubMed ID: 25531184
[TBL] [Abstract][Full Text] [Related]
33. The VP35 protein of Ebola virus inhibits the antiviral effect mediated by double-stranded RNA-dependent protein kinase PKR.
Feng Z; Cerveny M; Yan Z; He B
J Virol; 2007 Jan; 81(1):182-92. PubMed ID: 17065211
[TBL] [Abstract][Full Text] [Related]
34. Impact of Měnglà Virus Proteins on Human and Bat Innate Immune Pathways.
Williams CG; Gibbons JS; Keiffer TR; Luthra P; Edwards MR; Basler CF
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295912
[TBL] [Abstract][Full Text] [Related]
35. Ubiquitination of Ebola virus VP35 at lysine 309 regulates viral transcription and assembly.
van Tol S; Kalveram B; Ilinykh PA; Ronk A; Huang K; Aguilera-Aguirre L; Bharaj P; Hage A; Atkins C; Giraldo MI; Wakamiya M; Gonzalez-Orozco M; Warren AN; Bukreyev A; Freiberg AN; Rajsbaum R
PLoS Pathog; 2022 May; 18(5):e1010532. PubMed ID: 35533195
[TBL] [Abstract][Full Text] [Related]
36. The Ebola virus VP35 protein binds viral immunostimulatory and host RNAs identified through deep sequencing.
Dilley KA; Voorhies AA; Luthra P; Puri V; Stockwell TB; Lorenzi H; Basler CF; Shabman RS
PLoS One; 2017; 12(6):e0178717. PubMed ID: 28636653
[TBL] [Abstract][Full Text] [Related]
37. Characterization of the RNA silencing suppression activity of the Ebola virus VP35 protein in plants and mammalian cells.
Zhu Y; Cherukuri NC; Jackel JN; Wu Z; Crary M; Buckley KJ; Bisaro DM; Parris DS
J Virol; 2012 Mar; 86(6):3038-49. PubMed ID: 22238300
[TBL] [Abstract][Full Text] [Related]
38. Ebola virus VP35 perturbs type I interferon signaling to facilitate viral replication.
Cao Z; Liu C; Peng C; Ran Y; Yao Y; Xiao G; Li E; Chen Z; Chuai X; Chiu S
Virol Sin; 2023 Dec; 38(6):922-930. PubMed ID: 37839549
[TBL] [Abstract][Full Text] [Related]
39. Identification of Myricetin as an Ebola Virus VP35-Double-Stranded RNA Interaction Inhibitor through a Novel Fluorescence-Based Assay.
Daino GL; Frau A; Sanna C; Rigano D; Distinto S; Madau V; Esposito F; Fanunza E; Bianco G; Taglialatela-Scafati O; Zinzula L; Maccioni E; Corona A; Tramontano E
Biochemistry; 2018 Nov; 57(44):6367-6378. PubMed ID: 30298725
[TBL] [Abstract][Full Text] [Related]
40. Crystal Structure of the Marburg Virus Nucleoprotein Core Domain Chaperoned by a VP35 Peptide Reveals a Conserved Drug Target for Filovirus.
Zhu T; Song H; Peng R; Shi Y; Qi J; Gao GF
J Virol; 2017 Sep; 91(18):. PubMed ID: 28659479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
